🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/RT-2026-102Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

Retatrutide 10 mg

RT-2026-102Lot 8676-4Analyzed November 11, 2026
Retatrutide 10 mg vial as received

Timeline

Ordered
November 4, 2026
Received
November 10, 2026
Analyzed
November 11, 2026

Sample

Name
Retatrutide 10 mg
Expected
Retatrutide
Amount
1 vial, lyophilized powder

Testing

Client
Vexorix labs
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
11.67mg
Label claim: 10 mg
Purity, how clean it is
99.6%
by HPLC-UV peak area

Chromatogram

HPLC-UV

mAU-10001002000481216202428Retention time (min)18.31
18.31 min, Retatrutide, 99.6%

Analyst Comments

White lyophilized powder, white-cap vial, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 11, 2026

Verification Code

RT-B9P2-8AM2
Verify at purilab.org/verify/RT-B9P2-8AM2

Scan to Verify

RT-B9P2-8AM2

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1